Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
85.6M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
+76.8K
-
Total reported value, excl. options
-
$295M
-
Value change
-
+$5.24M
-
Number of buys
-
17
-
Number of sells
-
-13
-
Price
-
$21.41
Significant Holders of Larimar Therapeutics, Inc. - Common Stock (LRMR) as of Q4 2020
45 filings reported holding LRMR - Larimar Therapeutics, Inc. - Common Stock as of Q4 2020.
Larimar Therapeutics, Inc. - Common Stock (LRMR) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 85.6M outstanding shares and own 16.1% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5.14M shares), RA CAPITAL MANAGEMENT, L.P. (1.52M shares), CHI Advisors LLC (1.52M shares), ORBIMED ADVISORS LLC (887K shares), Acuta Capital Partners, LLC (863K shares), Vivo Capital, LLC (800K shares), Logos Global Management LP (715K shares), Atlas Venture Advisors, Inc. (292K shares), BlackRock Inc. (223K shares), and RENAISSANCE TECHNOLOGIES LLC (221K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.